National Cancer Institute Home at the National Institutes of Health | www.cancer.gov

Cancer Survival Statistics: References

Boer R, Ries L, van Ballegooijen M, Feuer E, Legler J, Habbema D. Ambiguities In Calculating Cancer Patient Survival: The SEER Experience for Colorectal and Prostate Cancer. Technical Report # 2003-05, Statistical Research and Applications Branch, National Cancer Institute 2003 (http://surveillance.cancer.gov/reports). [View PDF]

Brenner H, Hakulinen T. Advanced detection of time trends in long-term cancer patient survival: experience from 50 years of cancer registration in Finland. Am J Epidemiol 2002 Sep 15;156(6):566-77. [Full TextExternal Web Site Policy]

Brown CC. The statistical comparison of relative survival rates. Biometrics 1983;39:941-8. [View PreviewExternal Web Site Policy]

Cho H, Howlader N, Mariotto AB, Cronin KA.  Estimating relative survival for cancer patients from SEER using expected rates based on Ederer I versus Ederer II method. Surveillance Research Program, National Cancer Institute; 2011. Technical Report #2011-01. Available from: http://surveillance.cancer.gov/reports/. [View PDF]

Cronin KA, Feuer EJ. Cumulative cause-specific mortality for cancer patients in the presence of other causes: a crude analogue of relative survival. Stat Med 2000 Jul 15;19(13):1729-40. [View AbstractExternal Web Site Policy]

Cronin K, Mariotto A, Scoppa S, Green D, Clegg L. Differences Between Brenner et al. and NCI Methods for Calculating Period Survival. Technical Report # 2003-02, Statistical Research and Applications Branch, National Cancer Institute 2003 (http://surveillance.cancer.gov/reports). [View PDF]

Ederer F, Axtell LM, Cutler SJ. The relative survival rate: a statistical methodology. Natl Cancer Inst Monogr 1961;6:101-21.

Marubini E, Valsecchi MG. Analysing Survival Data from Clinical Trials and Observational Studies. England: John Wiley & Sons; 1995, pp 331-61.

Schairer C, Mink PJ, Carroll L, Devesa SS. Probabilities of Death From Breast Cancer and Other Causes Among Female Breast Cancer Patients. J Natl Cancer Inst 2004;96:1311-21.